Global Circulating Tumor Cells Market 2020 by Company, Regions, Type and Application, Forecast to 2025
Summary
Market Overview
The global Circulating Tumor Cells market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 19.5% in the forecast period of 2020 to 2025 and will expected to reach USD 2264.7 million by 2025, from USD 1109.7 million in 2019.
The Circulating Tumor Cells market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Circulating Tumor Cells market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Circulating Tumor Cells market has been segmented into CTC Enrichment, CTC Detection, CTC Analysis, etc.
By Application, Circulating Tumor Cells has been segmented into Breast Cancer, Prostate Cancer, Colorectal Cancer, Lung Cancer, Other, etc.
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Circulating Tumor Cells market presented in the report. This section sheds light on the sales growth of different regional and country-level Circulating Tumor Cells markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Circulating Tumor Cells market.
The report offers in-depth assessment of the growth and other aspects of the Circulating Tumor Cells market in important countries (regions), including United States, Canada, Mexico, Germany, France, United Kingdom, Russia, Italy, China, Japan, Korea, India, Southeast Asia, Australia, Brazil and Saudi Arabia, etc. It also throws light on the progress of key regional Circulating Tumor Cells markets such as North America, Europe, Asia-Pacific, South America and Middle East & Africa.
Competitive Landscape and Circulating Tumor Cells Market Share Analysis
Circulating Tumor Cells competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Circulating Tumor Cells sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Circulating Tumor Cells sales, revenue and market share for each player covered in this report.
The major players covered in Circulating Tumor Cells are: Menarini-Silicon Biosystems, SurExamBio-Tech, ApoCell, Qiagen (Adnagen), Cynvenio, Advanced Cell Diagnostics, Ikonisys, Greiner Bio-one GmbH, Epic Sciences, Fluxion Biosciences, Celsee, Hangzhou Watson Biotech, Clearbridge Biomedics, Guangzhou Wondfo Biotech, Biocept, ANGLE plc, CytoTrack, etc. Among other players domestic and global, Circulating Tumor Cells market share data is available for global, North America, Europe, Asia-Pacific, Middle East & Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
Table of Contents
1 Circulating Tumor Cells Market Overview
1.1 Product Overview and Scope of Circulating Tumor Cells
1.2 Classification of Circulating Tumor Cells by Type
1.2.1 Global Circulating Tumor Cells Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Circulating Tumor Cells Revenue Market Share by Type in 2019
1.2.3 CTC Enrichment
1.2.4 CTC Detection
1.2.5 CTC Analysis
1.3 Global Circulating Tumor Cells Market by Application
1.3.1 Overview: Global Circulating Tumor Cells Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Breast Cancer
1.3.3 Prostate Cancer
1.3.4 Colorectal Cancer
1.3.5 Lung Cancer
1.3.6 Other
1.4 Global Circulating Tumor Cells Market by Regions
1.4.1 Global Circulating Tumor Cells Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Circulating Tumor Cells (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Circulating Tumor Cells Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Circulating Tumor Cells Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Circulating Tumor Cells Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Circulating Tumor Cells Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Circulating Tumor Cells Status and Prospect (2015-2025)
2 Company Profiles
2.1 Menarini-Silicon Biosystems
2.1.1 Menarini-Silicon Biosystems Details
2.1.2 Menarini-Silicon Biosystems Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Menarini-Silicon Biosystems SWOT Analysis
2.1.4 Menarini-Silicon Biosystems Product and Services
2.1.5 Menarini-Silicon Biosystems Circulating Tumor Cells Revenue, Gross Margin and Market Share (2018-2019)
2.2 SurExamBio-Tech
2.2.1 SurExamBio-Tech Details
2.2.2 SurExamBio-Tech Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 SurExamBio-Tech SWOT Analysis
2.2.4 SurExamBio-Tech Product and Services
2.2.5 SurExamBio-Tech Circulating Tumor Cells Revenue, Gross Margin and Market Share (2018-2019)
2.3 ApoCell
2.3.1 ApoCell Details
2.3.2 ApoCell Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 ApoCell SWOT Analysis
2.3.4 ApoCell Product and Services
2.3.5 ApoCell Circulating Tumor Cells Revenue, Gross Margin and Market Share (2018-2019)
2.4 Qiagen (Adnagen)
2.4.1 Qiagen (Adnagen) Details
2.4.2 Qiagen (Adnagen) Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Qiagen (Adnagen) SWOT Analysis
2.4.4 Qiagen (Adnagen) Product and Services
2.4.5 Qiagen (Adnagen) Circulating Tumor Cells Revenue, Gross Margin and Market Share (2018-2019)
2.5 Cynvenio
2.5.1 Cynvenio Details
2.5.2 Cynvenio Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Cynvenio SWOT Analysis
2.5.4 Cynvenio Product and Services
2.5.5 Cynvenio Circulating Tumor Cells Revenue, Gross Margin and Market Share (2018-2019)
2.6 Advanced Cell Diagnostics
2.6.1 Advanced Cell Diagnostics Details
2.6.2 Advanced Cell Diagnostics Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Advanced Cell Diagnostics SWOT Analysis
2.6.4 Advanced Cell Diagnostics Product and Services
2.6.5 Advanced Cell Diagnostics Circulating Tumor Cells Revenue, Gross Margin and Market Share (2018-2019)
2.7 Ikonisys
2.7.1 Ikonisys Details
2.7.2 Ikonisys Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Ikonisys SWOT Analysis
2.7.4 Ikonisys Product and Services
2.7.5 Ikonisys Circulating Tumor Cells Revenue, Gross Margin and Market Share (2018-2019)
2.8 Greiner Bio-one GmbH
2.8.1 Greiner Bio-one GmbH Details
2.8.2 Greiner Bio-one GmbH Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Greiner Bio-one GmbH SWOT Analysis
2.8.4 Greiner Bio-one GmbH Product and Services
2.8.5 Greiner Bio-one GmbH Circulating Tumor Cells Revenue, Gross Margin and Market Share (2018-2019)
2.9 Epic Sciences
2.9.1 Epic Sciences Details
2.9.2 Epic Sciences Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Epic Sciences SWOT Analysis
2.9.4 Epic Sciences Product and Services
2.9.5 Epic Sciences Circulating Tumor Cells Revenue, Gross Margin and Market Share (2018-2019)
2.10 Fluxion Biosciences
2.10.1 Fluxion Biosciences Details
2.10.2 Fluxion Biosciences Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Fluxion Biosciences SWOT Analysis
2.10.4 Fluxion Biosciences Product and Services
2.10.5 Fluxion Biosciences Circulating Tumor Cells Revenue, Gross Margin and Market Share (2018-2019)
2.11 Celsee
2.11.1 Celsee Details
2.11.2 Celsee Major Business and Total Revenue (Financial Highlights) Analysis
2.11.3 Celsee SWOT Analysis
2.11.4 Celsee Product and Services
2.11.5 Celsee Circulating Tumor Cells Revenue, Gross Margin and Market Share (2018-2019)
2.12 Hangzhou Watson Biotech
2.12.1 Hangzhou Watson Biotech Details
2.12.2 Hangzhou Watson Biotech Major Business and Total Revenue (Financial Highlights) Analysis
2.12.3 Hangzhou Watson Biotech SWOT Analysis
2.12.4 Hangzhou Watson Biotech Product and Services
2.12.5 Hangzhou Watson Biotech Circulating Tumor Cells Revenue, Gross Margin and Market Share (2018-2019)
2.13 Clearbridge Biomedics
2.13.1 Clearbridge Biomedics Details
2.13.2 Clearbridge Biomedics Major Business and Total Revenue (Financial Highlights) Analysis
2.13.3 Clearbridge Biomedics SWOT Analysis
2.13.4 Clearbridge Biomedics Product and Services
2.13.5 Clearbridge Biomedics Circulating Tumor Cells Revenue, Gross Margin and Market Share (2018-2019)
2.14 Guangzhou Wondfo Biotech
2.14.1 Guangzhou Wondfo Biotech Details
2.14.2 Guangzhou Wondfo Biotech Major Business and Total Revenue (Financial Highlights) Analysis
2.14.3 Guangzhou Wondfo Biotech SWOT Analysis
2.14.4 Guangzhou Wondfo Biotech Product and Services
2.14.5 Guangzhou Wondfo Biotech Circulating Tumor Cells Revenue, Gross Margin and Market Share (2018-2019)
2.15 Biocept
2.15.1 Biocept Details
2.15.2 Biocept Major Business and Total Revenue (Financial Highlights) Analysis
2.15.3 Biocept SWOT Analysis
2.15.4 Biocept Product and Services
2.15.5 Biocept Circulating Tumor Cells Revenue, Gross Margin and Market Share (2018-2019)
2.16 ANGLE plc
2.16.1 ANGLE plc Details
2.16.2 ANGLE plc Major Business and Total Revenue (Financial Highlights) Analysis
2.16.3 ANGLE plc SWOT Analysis
2.16.4 ANGLE plc Product and Services
2.16.5 ANGLE plc Circulating Tumor Cells Revenue, Gross Margin and Market Share (2018-2019)
2.17 CytoTrack
2.17.1 CytoTrack Details
2.17.2 CytoTrack Major Business and Total Revenue (Financial Highlights) Analysis
2.17.3 CytoTrack SWOT Analysis
2.17.4 CytoTrack Product and Services
2.17.5 CytoTrack Circulating Tumor Cells Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Circulating Tumor Cells Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Circulating Tumor Cells Players Market Share
3.2.2 Top 10 Circulating Tumor Cells Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Circulating Tumor Cells Revenue and Market Share by Regions
4.2 North America Circulating Tumor Cells Revenue and Growth Rate (2015-2020)
4.3 Europe Circulating Tumor Cells Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Circulating Tumor Cells Revenue and Growth Rate (2015-2020)
4.5 South America Circulating Tumor Cells Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Circulating Tumor Cells Revenue and Growth Rate (2015-2020)
5 North America Circulating Tumor Cells Revenue by Countries
5.1 North America Circulating Tumor Cells Revenue by Countries (2015-2020)
5.2 USA Circulating Tumor Cells Revenue and Growth Rate (2015-2020)
5.3 Canada Circulating Tumor Cells Revenue and Growth Rate (2015-2020)
5.4 Mexico Circulating Tumor Cells Revenue and Growth Rate (2015-2020)
6 Europe Circulating Tumor Cells Revenue by Countries
6.1 Europe Circulating Tumor Cells Revenue by Countries (2015-2020)
6.2 Germany Circulating Tumor Cells Revenue and Growth Rate (2015-2020)
6.3 UK Circulating Tumor Cells Revenue and Growth Rate (2015-2020)
6.4 France Circulating Tumor Cells Revenue and Growth Rate (2015-2020)
6.5 Russia Circulating Tumor Cells Revenue and Growth Rate (2015-2020)
6.6 Italy Circulating Tumor Cells Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Circulating Tumor Cells Revenue by Countries
7.1 Asia-Pacific Circulating Tumor Cells Revenue by Countries (2015-2020)
7.2 China Circulating Tumor Cells Revenue and Growth Rate (2015-2020)
7.3 Japan Circulating Tumor Cells Revenue and Growth Rate (2015-2020)
7.4 Korea Circulating Tumor Cells Revenue and Growth Rate (2015-2020)
7.5 India Circulating Tumor Cells Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Circulating Tumor Cells Revenue and Growth Rate (2015-2020)
8 South America Circulating Tumor Cells Revenue by Countries
8.1 South America Circulating Tumor Cells Revenue by Countries (2015-2020)
8.2 Brazil Circulating Tumor Cells Revenue and Growth Rate (2015-2020)
8.3 Argentina Circulating Tumor Cells Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Circulating Tumor Cells by Countries
9.1 Middle East & Africa Circulating Tumor Cells Revenue by Countries (2015-2020)
9.2 Saudi Arabia Circulating Tumor Cells Revenue and Growth Rate (2015-2020)
9.3 UAE Circulating Tumor Cells Revenue and Growth Rate (2015-2020)
9.4 Egypt Circulating Tumor Cells Revenue and Growth Rate (2015-2020)
9.5 South Africa Circulating Tumor Cells Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Circulating Tumor Cells Revenue and Market Share by Type (2015-2020)
10.2 Global Circulating Tumor Cells Market Forecast by Type (2019-2024)
10.3 CTC Enrichment Revenue Growth Rate (2015-2025)
10.4 CTC Detection Revenue Growth Rate (2015-2025)
10.5 CTC Analysis Revenue Growth Rate (2015-2025)
11 Global Circulating Tumor Cells Market Segment by Application
11.1 Global Circulating Tumor Cells Revenue Market Share by Application (2015-2020)
11.2 Circulating Tumor Cells Market Forecast by Application (2019-2024)
11.3 Breast Cancer Revenue Growth (2015-2020)
11.4 Prostate Cancer Revenue Growth (2015-2020)
11.5 Colorectal Cancer Revenue Growth (2015-2020)
11.6 Lung Cancer Revenue Growth (2015-2020)
11.7 Other Revenue Growth (2015-2020)
12 Global Circulating Tumor Cells Market Size Forecast (2021-2025)
12.1 Global Circulating Tumor Cells Market Size Forecast (2021-2025)
12.2 Global Circulating Tumor Cells Market Forecast by Regions (2021-2025)
12.3 North America Circulating Tumor Cells Revenue Market Forecast (2021-2025)
12.4 Europe Circulating Tumor Cells Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Circulating Tumor Cells Revenue Market Forecast (2021-2025)
12.6 South America Circulating Tumor Cells Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Circulating Tumor Cells Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US
Tables and Figures
List of Tables
Table 1. Global Circulating Tumor Cells Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Circulating Tumor Cells by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Circulating Tumor Cells Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Circulating Tumor Cells Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Menarini-Silicon Biosystems Corporate Information, Location and Competitors
Table 6. Menarini-Silicon Biosystems Circulating Tumor Cells Major Business
Table 7. Menarini-Silicon Biosystems Circulating Tumor Cells Total Revenue (USD Million) (2017-2018)
Table 8. Menarini-Silicon Biosystems SWOT Analysis
Table 9. Menarini-Silicon Biosystems Circulating Tumor Cells Product and Solutions
Table 10. Menarini-Silicon Biosystems Circulating Tumor Cells Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 11. SurExamBio-Tech Corporate Information, Location and Competitors
Table 12. SurExamBio-Tech Circulating Tumor Cells Major Business
Table 13. SurExamBio-Tech Circulating Tumor Cells Total Revenue (USD Million) (2018-2019)
Table 14. SurExamBio-Tech SWOT Analysis
Table 15. SurExamBio-Tech Circulating Tumor Cells Product and Solutions
Table 16. SurExamBio-Tech Circulating Tumor Cells Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 17. ApoCell Corporate Information, Location and Competitors
Table 18. ApoCell Circulating Tumor Cells Major Business
Table 19. ApoCell Circulating Tumor Cells Total Revenue (USD Million) (2017-2018)
Table 20. ApoCell SWOT Analysis
Table 21. ApoCell Circulating Tumor Cells Product and Solutions
Table 22. ApoCell Circulating Tumor Cells Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 23. Qiagen (Adnagen) Corporate Information, Location and Competitors
Table 24. Qiagen (Adnagen) Circulating Tumor Cells Major Business
Table 25. Qiagen (Adnagen) Circulating Tumor Cells Total Revenue (USD Million) (2017-2018)
Table 26. Qiagen (Adnagen) SWOT Analysis
Table 27. Qiagen (Adnagen) Circulating Tumor Cells Product and Solutions
Table 28. Qiagen (Adnagen) Circulating Tumor Cells Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 29. Cynvenio Corporate Information, Location and Competitors
Table 30. Cynvenio Circulating Tumor Cells Major Business
Table 31. Cynvenio Circulating Tumor Cells Total Revenue (USD Million) (2017-2018)
Table 32. Cynvenio SWOT Analysis
Table 33. Cynvenio Circulating Tumor Cells Product and Solutions
Table 34. Cynvenio Circulating Tumor Cells Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 35. Advanced Cell Diagnostics Corporate Information, Location and Competitors
Table 36. Advanced Cell Diagnostics Circulating Tumor Cells Major Business
Table 37. Advanced Cell Diagnostics Circulating Tumor Cells Total Revenue (USD Million) (2017-2018)
Table 38. Advanced Cell Diagnostics SWOT Analysis
Table 39. Advanced Cell Diagnostics Circulating Tumor Cells Product and Solutions
Table 40. Advanced Cell Diagnostics Circulating Tumor Cells Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 41. Ikonisys Corporate Information, Location and Competitors
Table 42. Ikonisys Circulating Tumor Cells Major Business
Table 43. Ikonisys Circulating Tumor Cells Total Revenue (USD Million) (2017-2018)
Table 44. Ikonisys SWOT Analysis
Table 45. Ikonisys Circulating Tumor Cells Product and Solutions
Table 46. Ikonisys Circulating Tumor Cells Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 47. Greiner Bio-one GmbH Corporate Information, Location and Competitors
Table 48. Greiner Bio-one GmbH Circulating Tumor Cells Major Business
Table 49. Greiner Bio-one GmbH Circulating Tumor Cells Total Revenue (USD Million) (2017-2018)
Table 50. Greiner Bio-one GmbH SWOT Analysis
Table 51. Greiner Bio-one GmbH Circulating Tumor Cells Product and Solutions
Table 52. Greiner Bio-one GmbH Circulating Tumor Cells Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 53. Epic Sciences Corporate Information, Location and Competitors
Table 54. Epic Sciences Circulating Tumor Cells Major Business
Table 55. Epic Sciences Circulating Tumor Cells Total Revenue (USD Million) (2017-2018)
Table 56. Epic Sciences SWOT Analysis
Table 57. Epic Sciences Circulating Tumor Cells Product and Solutions
Table 58. Epic Sciences Circulating Tumor Cells Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 59. Fluxion Biosciences Corporate Information, Location and Competitors
Table 60. Fluxion Biosciences Circulating Tumor Cells Major Business
Table 61. Fluxion Biosciences Circulating Tumor Cells Total Revenue (USD Million) (2017-2018)
Table 62. Fluxion Biosciences SWOT Analysis
Table 63. Fluxion Biosciences Circulating Tumor Cells Product and Solutions
Table 64. Fluxion Biosciences Circulating Tumor Cells Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 65. Celsee Corporate Information, Location and Competitors
Table 66. Celsee Circulating Tumor Cells Major Business
Table 67. Celsee Circulating Tumor Cells Total Revenue (USD Million) (2017-2018)
Table 68. Celsee SWOT Analysis
Table 69. Celsee Circulating Tumor Cells Product and Solutions
Table 70. Celsee Circulating Tumor Cells Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 71. Hangzhou Watson Biotech Corporate Information, Location and Competitors
Table 72. Hangzhou Watson Biotech Circulating Tumor Cells Major Business
Table 73. Hangzhou Watson Biotech Circulating Tumor Cells Total Revenue (USD Million) (2017-2018)
Table 74. Hangzhou Watson Biotech SWOT Analysis
Table 75. Hangzhou Watson Biotech Circulating Tumor Cells Product and Solutions
Table 76. Hangzhou Watson Biotech Circulating Tumor Cells Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 77. Clearbridge Biomedics Corporate Information, Location and Competitors
Table 78. Clearbridge Biomedics Circulating Tumor Cells Major Business
Table 79. Clearbridge Biomedics Circulating Tumor Cells Total Revenue (USD Million) (2017-2018)
Table 80. Clearbridge Biomedics SWOT Analysis
Table 81. Clearbridge Biomedics Circulating Tumor Cells Product and Solutions
Table 82. Clearbridge Biomedics Circulating Tumor Cells Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 83. Guangzhou Wondfo Biotech Corporate Information, Location and Competitors
Table 84. Guangzhou Wondfo Biotech Circulating Tumor Cells Major Business
Table 85. Guangzhou Wondfo Biotech Circulating Tumor Cells Total Revenue (USD Million) (2017-2018)
Table 86. Guangzhou Wondfo Biotech SWOT Analysis
Table 87. Guangzhou Wondfo Biotech Circulating Tumor Cells Product and Solutions
Table 88. Guangzhou Wondfo Biotech Circulating Tumor Cells Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 89. Biocept Corporate Information, Location and Competitors
Table 90. Biocept Circulating Tumor Cells Major Business
Table 91. Biocept Circulating Tumor Cells Total Revenue (USD Million) (2017-2018)
Table 92. Biocept SWOT Analysis
Table 93. Biocept Circulating Tumor Cells Product and Solutions
Table 94. Biocept Circulating Tumor Cells Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 95. ANGLE plc Corporate Information, Location and Competitors
Table 96. ANGLE plc Circulating Tumor Cells Major Business
Table 97. ANGLE plc Circulating Tumor Cells Total Revenue (USD Million) (2017-2018)
Table 98. ANGLE plc SWOT Analysis
Table 99. ANGLE plc Circulating Tumor Cells Product and Solutions
Table 100. ANGLE plc Circulating Tumor Cells Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 101. CytoTrack Corporate Information, Location and Competitors
Table 102. CytoTrack Circulating Tumor Cells Major Business
Table 103. CytoTrack Circulating Tumor Cells Total Revenue (USD Million) (2017-2018)
Table 104. CytoTrack SWOT Analysis
Table 105. CytoTrack Circulating Tumor Cells Product and Solutions
Table 106. CytoTrack Circulating Tumor Cells Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 107. Global Circulating Tumor Cells Revenue (Million USD) by Players (2015-2020)
Table 108. Global Circulating Tumor Cells Revenue Share by Players (2015-2020)
Table 109. Global Circulating Tumor Cells Revenue (Million USD) by Regions (2015-2020)
Table 110. Global Circulating Tumor Cells Revenue Market Share by Regions (2015-2020)
Table 111. North America Circulating Tumor Cells Revenue by Countries (2015-2020)
Table 112. North America Circulating Tumor Cells Revenue Market Share by Countries (2015-2020)
Table 113. Europe Circulating Tumor Cells Revenue (Million USD) by Countries (2015-2020)
Table 114. Asia-Pacific Circulating Tumor Cells Revenue (Million USD) by Countries (2015-2020)
Table 115. South America Circulating Tumor Cells Revenue by Countries (2015-2020)
Table 116. South America Circulating Tumor Cells Revenue Market Share by Countries (2015-2020)
Table 117. Middle East and Africa Circulating Tumor Cells Revenue (Million USD) by Countries (2015-2020)
Table 118. Middle East and Africa Circulating Tumor Cells Revenue Market Share by Countries (2015-2020)
Table 119. Global Circulating Tumor Cells Revenue (Million USD) by Type (2015-2020)
Table 120. Global Circulating Tumor Cells Revenue Share by Type (2015-2020)
Table 121. Global Circulating Tumor Cells Revenue Forecast by Type (2021-2025)
Table 122. Global Circulating Tumor Cells Revenue by Application (2015-2020)
Table 123. Global Circulating Tumor Cells Revenue Share by Application (2015-2020)
Table 124. Global Circulating Tumor Cells Revenue Forecast by Application (2021-2025)
Table 125. Global Circulating Tumor Cells Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Circulating Tumor Cells Picture
Figure 2. Global Circulating Tumor Cells Revenue Market Share by Type in 2019
Figure 3. CTC Enrichment Picture
Figure 4. CTC Detection Picture
Figure 5. CTC Analysis Picture
Figure 6. Circulating Tumor Cells Revenue Market Share by Application in 2019
Figure 7. Breast Cancer Picture
Figure 8. Prostate Cancer Picture
Figure 9. Colorectal Cancer Picture
Figure 10. Lung Cancer Picture
Figure 11. Other Picture
Figure 12. Global Circulating Tumor Cells Revenue (USD Million) and Growth Rate (2015-2025)
Figure 13. North America Circulating Tumor Cells Revenue (Million USD) and Growth Rate (2015-2025)
Figure 14. Europe Circulating Tumor Cells Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. Asia-Pacific Circulating Tumor Cells Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. South America Circulating Tumor Cells Revenue (Million USD) and Growth Rate (2015-2025)
Figure 17. Middle East and Africa Circulating Tumor Cells Revenue (Million USD) and Growth Rate (2015-2025)
Figure 18. Global Circulating Tumor Cells Revenue (Million USD) and Growth Rate (2015-2025)
Figure 19. Global Circulating Tumor Cells Revenue Share by Players in 2019
Figure 20. Global Top 5 Players Circulating Tumor Cells Revenue Market Share in 2019
Figure 21. Global Top 10 Players Circulating Tumor Cells Revenue Market Share in 2019
Figure 22. Key Players Market Share Trend
Figure 23. Global Circulating Tumor Cells Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 24. Global Circulating Tumor Cells Revenue Market Share by Regions (2015-2020)
Figure 25. Global Circulating Tumor Cells Revenue Market Share by Regions in 2018
Figure 26. North America Circulating Tumor Cells Revenue and Growth Rate (2015-2020)
Figure 27. Europe Circulating Tumor Cells Revenue and Growth Rate (2015-2020)
Figure 28. Asia-Pacific Circulating Tumor Cells Revenue and Growth Rate (2015-2020)
Figure 29. South America Circulating Tumor Cells Revenue and Growth Rate (2015-2020)
Figure 30. Middle East and Africa Circulating Tumor Cells Revenue and Growth Rate (2015-2020)
Figure 31. North America Circulating Tumor Cells Revenue Market Share by Countries (2015-2020)
Figure 32. North America Circulating Tumor Cells Revenue Market Share by Countries in 2019
Figure 33. USA Circulating Tumor Cells Revenue and Growth Rate (2015-2020)
Figure 34. Canada Circulating Tumor Cells Revenue and Growth Rate (2015-2020)
Figure 35. Mexico Circulating Tumor Cells Revenue and Growth Rate (2015-2020)
Figure 36. Europe Circulating Tumor Cells Revenue Market Share by Countries (2015-2020)
Figure 37. Europe Circulating Tumor Cells Revenue Market Share by Countries in 2019
Figure 38. Germany Circulating Tumor Cells Revenue and Growth Rate (2015-2020)
Figure 39. UK Circulating Tumor Cells Revenue and Growth Rate (2015-2020)
Figure 40. France Circulating Tumor Cells Revenue and Growth Rate (2015-2020)
Figure 41. Russia Circulating Tumor Cells Revenue and Growth Rate (2015-2020)
Figure 42. Italy Circulating Tumor Cells Revenue and Growth Rate (2015-2020)
Figure 43. Asia-Pacific Circulating Tumor Cells Revenue Market Share by Countries (2015-2020)
Figure 44. Asia-Pacific Circulating Tumor Cells Revenue Market Share by Countries in 2019
Figure 45. China Circulating Tumor Cells Revenue and Growth Rate (2015-2020)
Figure 46. Japan Circulating Tumor Cells Revenue and Growth Rate (2015-2020)
Figure 47. Korea Circulating Tumor Cells Revenue and Growth Rate (2015-2020)
Figure 48. India Circulating Tumor Cells Revenue and Growth Rate (2015-2020)
Figure 49. Southeast Asia Circulating Tumor Cells Revenue and Growth Rate (2015-2020)
Figure 50. South America Circulating Tumor Cells Revenue Market Share by Countries (2015-2020)
Figure 51. South America Circulating Tumor Cells Revenue Market Share by Countries in 2019
Figure 52. Brazil Circulating Tumor Cells Revenue and Growth Rate (2015-2020)
Figure 53. Argentina Circulating Tumor Cells Revenue and Growth Rate (2015-2020)
Figure 54. Middle East and Africa Circulating Tumor Cells Revenue Market Share by Countries (2015-2020)
Figure 55. Middle East and Africa Circulating Tumor Cells Revenue Market Share by Countries in 2019
Figure 56. Saudi Arabia Circulating Tumor Cells Revenue and Growth Rate (2015-2020)
Figure 57. UAE Circulating Tumor Cells Revenue and Growth Rate (2015-2020)
Figure 58. Egypt Circulating Tumor Cells Revenue and Growth Rate (2015-2020)
Figure 59. South Africa Circulating Tumor Cells Revenue and Growth Rate (2015-2020)
Figure 60. Global Circulating Tumor Cells Revenue Share by Type (2015-2020)
Figure 61. Global Circulating Tumor Cells Revenue Share by Type in 2019
Figure 62. Global Circulating Tumor Cells Market Share Forecast by Type (2021-2025)
Figure 63. Global CTC Enrichment Revenue Growth Rate (2015-2020)
Figure 64. Global CTC Detection Revenue Growth Rate (2015-2020)
Figure 65. Global CTC Analysis Revenue Growth Rate (2015-2020)
Figure 66. Global Circulating Tumor Cells Revenue Share by Application (2015-2020)
Figure 67. Global Circulating Tumor Cells Revenue Share by Application in 2019
Figure 68. Global Circulating Tumor Cells Market Share Forecast by Application (2021-2025)
Figure 69. Global Breast Cancer Revenue Growth Rate (2015-2020)
Figure 70. Global Prostate Cancer Revenue Growth Rate (2015-2020)
Figure 71. Global Colorectal Cancer Revenue Growth Rate (2015-2020)
Figure 72. Global Lung Cancer Revenue Growth Rate (2015-2020)
Figure 73. Global Other Revenue Growth Rate (2015-2020)
Figure 74. Global Circulating Tumor Cells Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 75. Global Circulating Tumor Cells Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 76. Global Circulating Tumor Cells Revenue Market Share Forecast by Regions (2021-2025)
Figure 77. North America Circulating Tumor Cells Revenue Market Forecast (2021-2025)
Figure 78. Europe Circulating Tumor Cells Revenue Market Forecast (2021-2025)
Figure 79. Asia-Pacific Circulating Tumor Cells Revenue Market Forecast (2021-2025)
Figure 80. South America Circulating Tumor Cells Revenue Market Forecast (2021-2025)
Figure 81. Middle East and Africa Circulating Tumor Cells Revenue Market Forecast (2021-2025)
Figure 82. Sales Channel: Direct Channel vs Indirect Channel
Reason to Buy
- Current and future of Pharma & Healthcare Market outlook in the developed and emerging markets
- Highlights key business priorities in order to assist companies to realign their business strategies
- The segment that is expected to dominate the Pharma & Healthcare Market
- Regions that are expected to witness the fastest growth during the forecast period
- Identify the latest developments, Pharma & Healthcare Market shares, and strategies employed by the major market players
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Pharma & Healthcare Market
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets